Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688402 | SCV000816012 | likely benign | Intellectual disability, autosomal dominant 8 | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317916 | SCV000851410 | uncertain significance | Inborn genetic diseases | 2025-01-21 | criteria provided, single submitter | clinical testing | The c.1012G>A (p.V338M) alteration is located in exon 7 (coding exon 7) of the GRIN1 gene. This alteration results from a G to A substitution at nucleotide position 1012, causing the valine (V) at amino acid position 338 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV001508287 | SCV001714341 | uncertain significance | not provided | 2019-10-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001508287 | SCV001814176 | likely benign | not provided | 2020-12-09 | criteria provided, single submitter | clinical testing |